|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Gemini Therapeutics (NASDAQ: GMTX) through any online brokerage.
The latest price target for Gemini Therapeutics (NASDAQ: GMTX) was reported by SVB Leerink on April 8, 2021. The analyst firm set a price target for 25.00 expecting GMTX to rise to within 12 months (a possible 273.69% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Gemini Therapeutics (NASDAQ: GMTX) is $6.69 last updated Wed Jun 23 2021 20:00:04 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Gemini Therapeutics.
There is no upcoming split for Gemini Therapeutics.
Gemini Therapeutics is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.